Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06373432 · ClinicalTrials.gov registry record · NA
Frequency of Glucose Monitoring in Labor
A NA study of Neonatal Hypoglycemia, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06373432 is a NA study of Neonatal Hypoglycemia that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 100 participants, below the 122-participant average among 5 other Neonatal Hypoglycemia trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06373432, a NA study of Neonatal Hypoglycemia, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to assess rates of neonatal hypoglycemia with differing intrapartum glucose protocols. Currently at this time there is no guidance from professional medical organizations about when and how frequent to assess maternal glucose levels intrapartum. Several institutions have no protocols in place. The study will be a randomized controlled trial placing patients with Gestational Diabetes Mellitus (GDM) in "frequent" vs "infrequent" glucose monitoring intrapartum and assessing neonatal glucose levels at birth.
Conditions Studied
Interventions
- OTHER Fingerstick
Study Locations (1)
New York
- Mount Sinai West Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2025-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06373432
The ClinicalTrials.gov registry entry for NCT06373432 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 122-participant average among 5 other Neonatal Hypoglycemia trials with a reported enrollment target (18% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neonatal Hypoglycemia appearing as the primary indexed condition, and to 1 intervention - of which Fingerstick is the first listed.
NCT06373432 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06373432 about?
NCT06373432 is a clinical study titled "Frequency of Glucose Monitoring in Labor". The aim of this study is to assess rates of neonatal hypoglycemia with differing intrapartum glucose protocols. Currently at this time there is no guidance from professional medical organizations about when and how frequent to assess maternal glucose levels intrapartum. Several institutions have no ...
What is the current status of trial NCT06373432?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2024-05-01. Estimated completion is 2025-05-30.
What conditions does trial NCT06373432 study?
This clinical trial studies the following conditions: Neonatal Hypoglycemia.
What interventions are being tested in trial NCT06373432?
The interventions under investigation include: Fingerstick (OTHER).
Who is sponsoring clinical trial NCT06373432?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06373432 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Hypoglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
RECRUITING · NA
-
The Feasibility of Cream for Treatment of Neonatal Hypoglycemia
RECRUITING · NA
-
Continuous Glucose Monitoring in At-Risk Newborns
RECRUITING · NA
-
Effectiveness of Donor Human Milk Supplementation for the Treatment of Hypoglycemia in the Breastfed Infant
COMPLETED · NA
-
Continuous Glucose Monitoring in Infants
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.